Pharmaceuticals News and Research

RSS

Debt deal leaves health programs (mostly) intact

A final deal cut between President Joe Biden and House Republicans extends the U.S. debt ceiling deadline to 2025 and reins in some spending.

8 Jun 2023

Experimental drug may slow the progression of atherosclerosis

An experimental drug already tested as a potential treatment for cancer, lung disease, and Alzheimer's disease may slow the progression of atherosclerosis that leads to heart disease, a new study shows.

8 Jun 2023

AI program can read physicians' notes to make useful assessments about patient health status

An artificial intelligence (AI) computer program can read physicians' notes to accurately estimate patients' risk of death, length of hospital stay, and other factors important to care.

7 Jun 2023

Promising targeted therapy offers new hope to certain patients with advanced pancreatic cancer

A promising new targeted cancer therapy will soon be available to certain patients with advanced pancreatic cancer – from the comfort of their home.

7 Jun 2023

Study suggests possible new treatment option for people with slow-growing but deadly brain tumor

In an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend the amount of time people with a subtype of glioma are on treatment without their cancer worsening.

4 Jun 2023

Study offers the most comprehensive archive of cellular, molecular features involved in psoriatic disease

Beneath and beyond the reddish, flaky lesions that form in the skin of those with psoriasis, mild and severe forms of the disease can be told apart by the activity of key cells and signaling pathways, a new study shows.

2 Jun 2023

Lupus Therapeutics announces three Phase 3 clinical trials testing new therapies for SLE and lupus nephritis

Lupus Therapeutics announced the start of a collaboration to conduct three Phase 3 clinical trials testing an investigational therapeutic ianalumab for systemic lupus erythematosus and lupus nephritis.

2 Jun 2023

Many people living in the ‘diabetes belt’ are plagued with medical debt

Delores Lowery remembers vividly the day in 2016 when she was working in a weaving plant near her home in Bennettsville, South Carolina, and the world around her seemed to go dim.

30 May 2023

High prevalence of galactagogue use among breastfeeding mothers in U.S.

Researchers describe the prevalence of galactagogue use among breastfeeding mothers in the United States and their perceived effects on milk production.

29 May 2023

Physical activity in the afternoon provides greatest improvements in glucose control for patients with type 2 diabetes

Over 37 million Americans have diabetes, and 90-95% of that population are diagnosed with type 2 diabetes.

25 May 2023

This panel will decide whose medicine to make affordable. Its choice will be tricky.

Catherine Reitzel's multiple sclerosis medication costs nearly $100,000 a year. Kris Garcia relies on a drug for a blood-clotting disorder that runs $10,000 for a three-day supply. And Mariana Marquez-Farmer would likely die within days without her monthly $300 vial of insulin.

25 May 2023

Bridging the Gap between Academia and Industry: The Power of Collaboration in Life Sciences

In this behind-the-scenes interview, we speak to Dr. Sinead Knight, chair of SLAS Europe 2023, about this years programme, highlighting the key topics and speakers.

From Society for Laboratory Automation and Screening (SLAS) 25 May 2023

Study maps cellular responses to blood sugar

Researchers at The University of Texas at El Paso have successfully mapped specific regions in the brain that are activated in association with changes in blood sugar -; also known as glucose -; providing fundamental location information that could ultimately lead to more targeted therapies for people who struggle with conditions like diabetes.

25 May 2023

$Using 3D-electron diffraction to determine the structure of Levocetirizine dihydrochloride$

Using 3D-electron diffraction to determine the structure of Levocetirizine dihydrochloride

For pharmaceuticals, knowing the chemical composition is not enough-;molecular geometry and crystal structure also play an important role in a drug's activity.

23 May 2023

Modified version of anti-nausea drug can enter into cells and provide long-lasting pain relief

Altering the chemical properties of an anti-nausea drug enables it to enter an interior compartment of the cell and provide long-lasting pain relief, according to a new study led by researchers at NYU College of Dentistry's Pain Research Center.

22 May 2023

Targeting mucus plugs could help prevent deaths from COPD, study suggests

A retrospective analysis of patient data from the COPDGene study suggests that targeting mucus plugs could help prevent deaths from chronic obstructive pulmonary disease-;the fourth leading cause of death in the United States.

22 May 2023

The role of RNA splicing in one of the deadliest forms of pancreatic cancer

In this interview, we spoke to Adrian Krainer, a Professor at Cold Spring Harbor Laboratory, about his latest research into the role of RNA splicing in one of the deadliest forms of pancreatic cancer.

22 May 2023

A more aggressive FTC is starting to target drug mergers and industry middlemen

Under the leadership of an aggressive opponent of anti-competitive business practices, the Federal Trade Commission is moving against drug companies and industry middlemen as part of the Biden administration's push for lower drug prices at the pharmacy counter.

22 May 2023

Are US prescription drug prices 10 times those of other nations? Only sometimes

Sen. Bernie Sanders (I-Vt.), whether in Congress or as a presidential candidate, has always taken strong positions against the high cost of prescription drugs.

19 May 2023

A rural county’s choice: Use opioid funds to pay off debt, or pay them forward to curb crisis

Over the past two years, rural Greene County in northeastern Tennessee has collected more than $2.7 million from regional and national settlements with opioid manufacturers and distributors.

16 May 2023

1
2
3
4
...
1247
Next

Pharmaceuticals News and Research

Debt deal leaves health programs (mostly) intact

Experimental drug may slow the progression of atherosclerosis

AI program can read physicians' notes to make useful assessments about patient health status

Promising targeted therapy offers new hope to certain patients with advanced pancreatic cancer

Study suggests possible new treatment option for people with slow-growing but deadly brain tumor

Study offers the most comprehensive archive of cellular, molecular features involved in psoriatic disease

Lupus Therapeutics announces three Phase 3 clinical trials testing new therapies for SLE and lupus nephritis

Many people living in the ‘diabetes belt’ are plagued with medical debt

High prevalence of galactagogue use among breastfeeding mothers in U.S.

Physical activity in the afternoon provides greatest improvements in glucose control for patients with type 2 diabetes

This panel will decide whose medicine to make affordable. Its choice will be tricky.

Bridging the Gap between Academia and Industry: The Power of Collaboration in Life Sciences

Study maps cellular responses to blood sugar

Using 3D-electron diffraction to determine the structure of Levocetirizine dihydrochloride

Modified version of anti-nausea drug can enter into cells and provide long-lasting pain relief

Targeting mucus plugs could help prevent deaths from COPD, study suggests

The role of RNA splicing in one of the deadliest forms of pancreatic cancer

A more aggressive FTC is starting to target drug mergers and industry middlemen

Are US prescription drug prices 10 times those of other nations? Only sometimes

A rural county’s choice: Use opioid funds to pay off debt, or pay them forward to curb crisis

Exploring the intersection of biology and proteomics

Unlocking the Secrets of Multiple Sclerosis Progression: Brain-Immune Cell Communication

Passing on Polycystic Ovary Syndrome: Health risks for male offspring of women with PCOS

Latest Life Science News